Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова» Минздрава России, Санкт-Петербург, Россия kushnir.yana2014@yandex.ru
Список исп. литературыСкрыть список 1. Van den Bergh PYK, van Doorn PA, Hadden RDM et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. Journal of the peripheral nervous system : JPNS. 2021;26(3):242-68. DOI: 10.1111/jns.12455 2. Rezania K, Gundogdu B, Soliven B. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. Front Biosci. 2004;9:939-45. DOI: 10.2741/1286 3. Lim JY, Lim YH, Choi EH. Acute-onset chronic inflammatory demyelinating polyneuropathy in hantavirus and hepatitis B virus coinfection: A case report. Medicine (Baltimore). 2016;95(49):e5580. DOI: 10.1097/MD.0000000000005580 4. Stübgen JP. A review of the use of biological agents for chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Sci. 2013;326(1-2):1-9. DOI: 10.1016/j.jns.2013.01.003 5. Altinkaya A, Topcular B, Sakalli NK et al. Chronic inflammatory demyelinating polyradiculoneuropathy associated intracranial hypertension. Neurol Sci. 2013;34(6):1027-29. DOI: 10.1007/s10072-012-1179-6 6. Gaebel K, Blackhouse G, Campbell K et al. Intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Open Med. 2010;4(3):e154-e166. 7. Rajabally YA, Simpson BS, Beri S et al. Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population. Muscle & nerve. 2009;39(4):432-8. DOI: 10.1002/mus.21206 8. Broers MC, Bunschoten C, Nieboer D et al. Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis. Neuroepidemiology. 2019;52(3-4):161-72. DOI: 10.1159/000494291 9. Koike H, Katsuno M. Paraproteinemia and neuropathy. Neurological sciences. 2021;42(11):4489-501. DOI: 10.1007/s10072-021- 05583-7 10. Rajabally Y, Perić S, Bozovic I et al. Antecedent infections and vaccinations in chronic inflammatory demyelinating polyneuropathy: A European collaborative study. Muscle & Nerve. 2021;64:657-61. DOI: 10.1002/mus.27374 11. Goedee H. Antecedent infections in CIDP: A relevant clue in a complex disease? Muscle & Nerve. 2021;64. DOI: 10.1002/mus.27424. 12. Doneddu PE, Bianchi E, Cocito D et al; Italian CIDP Database Study Group Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database. European Journal of Neurology. 2020;27(1):136-43. DOI: 10.1111/ene.14044 13. Shabani Z. Demyelination as a result of an immune response in patients with COVID-19. Acta neurologica Belgica. 2021;121(4):859-66. DOI: 10.1007/s13760-021-01691-5 14. Abu-Rumeileh S, Garibashvili T, Ruf W et al. Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19. Journal of the Neurological Sciences. 2020;418:117106. DOI: 10.1016/j.jns.2020.117106 15. Patel D, Mandal G, Chukwueke L, Woods K. A Rare Case of COVID-19-Induced Chronic Demyelinating Polyneuropathy. Cureus. 2022;14(5), e25165. DOI: 10.7759/cureus.25165 16. Van Looy E, Veenker L, Steyaert A et al. COVID-19-induced exacerbation of chronic inflammatory demyelinating polyneuropathy. Journal of neurology. 2021;268(9):3129-31. DOI: 10.1007/s00415-021-10417-9 17. Suri V, Pandey S, Singh J, Jena A. Acute-onset chronic inflammatory demyelinating polyneuropathy after COVID-19 infection and subsequent ChAdOx1 nCoV-19 vaccination. BMJ case reports. 2021;14(10):e245816. DOI: 10.1136/bcr-2021-245816 18. Fotiadou A, Tsiptsios D, Karatzetzou S et al. Acute-onset chronic inflammatory demyelinating polyneuropathy complicating SARS-CoV-2 infection and Ad26.COV2.S vaccination: report of two cases. The Egyptian journal of neurology, psychiatry and neurosurgery. 2022;58(1):116. DOI: 10.1186/s41983-022-00515-4 19. Abedi Samakoush M, Davoodi L, Khademian M et al. New-onset chronic inflammatory demyelinating polyradiculoneuropathy after COVID-19 infection: a case report. Annals of medicine and surgery.2023;85(10):5031-34. DOI: 10.1097/MS9.0000000000000352 20. Welborn BL, Benjamin J. Development of Lewis-Sumner Syndrome or Multifocal Acquired Demyelinating Sensory and Motor Neuropathy (MADSAM) Following COVID-19 Infection. Cureus. 2023;15(10): e46643. DOI: 10.7759/cureus.46643 21. Elshebawy H, Ezzeldin MY, Elzamarany EH. Characteristics of COVID and post COVID polyneuropathies in adults and pediatrics: an Egyptian sample. The Egyptian journal of neurology, psychiatry and neurosurgery. 2021;57(1):178. DOI: 10.1186/s41983-021-00435-9 22. Ateş MF, Kendirli S, Karşıdağ S et al. Acute Onset Chronic Inflammatory Demyelinating Polyneuropathy Following COVID-19. Duzce Medical Journal. 2022;24(1):95-7. DOI: 10.18678/dtfd.1034475 23. Taquet M, Geddes JR, Husain M et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. The lancet. Psychiatry. 2021;8(5):416-27. DOI: 10.1016/S2215-0366(21)00084-5 24. Hasrat NH, Kadhum HJ, Hashim AR et al. Neurographic Evidence of Inflammatory Polyneuropathies in Peri-COVID-19 Circumstances and Their Relationship With Acute Disease Severity and Inflammatory Storm. Cureus. 2022;14(3):e23517. DOI: 10.7759/cureus.23517